Creative Touch Permanent Makeup and Aesthetics

Skin dysbiosis describes the shift from a diverse, commensal-dominated skin microbiome toward a depleted, low-diversity community in which potentially pathogenic species – most significantly Staphylococcus aureus – establish and expand. It is not a diagnosis in isolation but a state: one that sits at the intersection of barrier biology, microbiology, and inflammation. What makes dysbiosis clinically significant is its self-reinforcing character. Barrier disruption creates the conditions for dysbiosis; dysbiosis actively worsens the barrier through virulence factor production, filaggrin degradation, and inflammatory amplification. The driver of this cascade is pH – the acid mantle’s shift from the 4.7–5.5 range that sustains commensals toward the near-neutral environment that S. aureus is specifically adapted to exploit. Dysbiosis is also a treatment-response modifier: actively dysbiotic skin produces consistently poorer outcomes from standard barrier interventions than the visible presentation would predict.

Skin dysbiosis is the shift in the skin’s microbial community from a diverse, acid-tolerant, commensal-dominated ecosystem toward a depleted state characterised by reduced species diversity and the expansion of conditionally pathogenic organisms. It is not a skin condition in the conventional sense – there is no dysbiosis diagnosis and no dysbiosis treatment pathway in mainstream medicine – but it is a biological state with specific, measurable consequences for barrier integrity, inflammatory tone, and responsiveness to treatment. Understanding it requires understanding what a healthy skin microbiome actually does, because dysbiosis is defined entirely by the loss of those functions.

The Baseline: What a Balanced Skin Microbiome Does

On healthy skin, the microbial community is not merely tolerated – it actively contributes to the barrier environment. Staphylococcus epidermidis, the dominant commensal on most skin surfaces, secretes sphingomyelinase that converts host sphingomyelin into ceramides, contributes an additive source of barrier lipids, and trains keratinocytes via TLR2 signalling to produce targeted antimicrobial peptides ( LL-37, β-defensin-3) whilst simultaneously suppressing NF-κB overstimulation. ^[12] Cutibacterium acnes, on sebaceous skin, ferments sebum fatty acids to produce propionic acid, which activates PPARα receptors in keratinocytes and stimulates filaggrin and loricrin expression in keratinocyte culture models alongside barrier lipid synthesis (though the magnitude of FLG/LOR induction is model-dependent and attenuated in 3D reconstructed epidermis systems). ^[1] The same propionic acid helps maintain the acidic surface pH that creates inhospitable conditions for S. aureus. Corynebacterium species, dominant on moist skin sites, contribute to microbial diversity and have been shown to inhibit S. aureus quorum sensing directly. ^[9]

The community is held in balance by the acid mantle – the pH 4.7–5.5 environment of the middle stratum corneum maintained by free fatty acid generation, NMF-derived acids (urocanic acid, pyrrolidone carboxylic acid from filaggrin proteolysis), and the NHE1 proton pump. This acidic environment is selectively hospitable: acid-tolerant commensals thrive in it; S. aureus, which grows optimally at pH 6–7, is kept suppressed by it. The acid mantle is not background chemistry – it is the primary ecological condition that makes commensal dominance possible.

How Dysbiosis Develops: The Self-Reinforcing Loop

Dysbiosis does not begin with microbes. It begins with pH.

When the acid mantle is disrupted – by alkaline cleansers, hard water mineral deposits, filaggrin deficiency reducing urocanic acid production, NHE1 decline in ageing skin, or the tight junction disruption that collapses the lower stratum corneum pH zone independently of surface chemistry – the ecological conditions that sustain commensals are removed. Surface pH shifts from approximately 5.0 toward the 6.0–7.0 range. Acid-tolerant S. epidermidis and C. acnes populations decline. The antimicrobial peptides those commensals were stimulating – LL-37 and the β-defensins – are no longer produced in adequate concentrations to maintain pathogen exclusion. The habitat becomes permissive for S. aureus. ^[7]

Once S. aureus populations cross a critical threshold, a qualitative shift occurs. S. aureus monitors its own population density through the Agr quorum-sensing system – a cell-to-cell signalling mechanism based on autoinducing peptides (AIPs). Below a population threshold, S. aureus behaves as a relatively tolerated organism. Once quorum is reached, Agr activation switches on a virulence programme: production of α-toxin and δ-toxin (which degrade the AMPs that were keeping it controlled), serine proteases that directly cleave filaggrin from the stratum corneum, biofilm formation that resists both host immune clearance and topical antibiotic penetration, and cytotoxins that trigger keratinocyte apoptosis and amplify IL-1β, IL-18, and Th2 cytokine signalling through NLRP1 inflammasome activation. ^{[9] [3]}

The filaggrin destruction is the step that closes the loop. Filaggrin proteolysis produces the urocanic acid and pyrrolidone carboxylic acid that are two of the acid mantle’s four generation mechanisms. When S. aureus proteases degrade filaggrin, they remove this acidification capacity, raising surface pH further – which in turn creates more favourable conditions for continued S. aureus dominance. The barrier disruption that initiated dysbiosis is now actively worsened by the dysbiosis itself.

Clinical Pearl The quorum-sensing threshold is clinically observable even without sequencing data. Skin that appears mildly reactive and then deteriorates sharply is exhibiting the Agr activation dynamic: below threshold, S. aureus is present but behaving; at threshold, the virulence programme switches on and the clinical picture changes faster than any single environmental trigger explains. Intervening before that tipping point – addressing the pH environment and commensal support early – is mechanistically more effective than managing the established dysbiotic state.

What Disrupts the Acid Mantle and Triggers the Loop

The triggers of dysbiosis are diverse in origin but unified by mechanism – they all operate through the same first step of acid mantle disruption or commensal habitat destabilisation:

• Alkaline cleansers and SLS-based surfactants raise stratum corneum pH by 1.5–2 units for up to four hours post-wash, removing surface FFAs and disrupting the NMF acid pool. In twice-daily use, the acid mantle never fully re-establishes between washes.

• Hard water introduces calcium and magnesium ions that react with surface free fatty acids to form insoluble calcium stearate deposits, physically stripping FFAs from the acid mantle with each wash cycle – a pH-raising mechanism that is distinct from and compounds alkaline surfactant damage.

• Topical antibiotic overuse selectively reduces C. acnes and S. epidermidis populations, removing both the PPARα lipid synthesis signal and the commensal-derived AMP production that controls S. aureus – the microbiome cost of antibiotic therapy that is rarely weighed explicitly in prescribing decisions.

• Filaggrin deficiency – genetic (FLG null variants) or acquired ( IL-4/ IL-13 suppression) – reduces urocanic acid and PCA production, eliminating two of four acid mantle generation mechanisms. FLG loss-of-function is associated with altered lesional microbiome composition in atopic dermatitis – a direct link between barrier genetics and microbiome ecology, though the specific directionality of S. aureus enrichment by FLG genotype varies by population studied. ^[8]

• Psychological stress activates the HPA axis, raising cortisol and catecholamines that impair keratinocyte differentiation, suppress barrier lipid synthesis (cortisol inhibits HMG- CoA reductase independently), and increase TEWL – all of which alter the skin surface environment toward dysbiosis-permissive conditions.

• NHE1 decline with age reduces the active proton-pumping mechanism that maintains stratum corneum acidity independently of FFA generation or filaggrin status. This is an age-related driver that operates quietly, contributes to the progressive alkaline shift of aged skin, and is not corrected by ceramide products or barrier lipid supplementation alone.

• UV radiation and air pollution alter microbiome composition through direct and indirect mechanisms, promoting lipophilic organism growth whilst disrupting commensal balance at the community level.

What Dysbiotic Skin Looks and Feels Like

This is where clinical knowledge diverges from what the literature typically describes. In practice, dysbiotic skin has a recognisable character that goes beyond “inflamed and dry.”

The pattern most frequently encountered is skin that cycles: it improves with barrier-supportive intervention, then relapses – not dramatically, but with a consistency that doesn’t match the quality of the homecare or the treatments being used. The erythema is diffuse rather than focal, often most visible at the cheeks and perioral area in facial presentations, and it doesn’t fully clear between flares. The texture has a quality of both dryness and mild oedema simultaneously – dehydration and low-grade inflammation existing in the same tissue. The skin responds to moisturiser and feels temporarily comfortable, then deteriorates within hours in a way that simple dehydration would not explain. It may not fit cleanly into atopic dermatitis, contact dermatitis, or sensitivity categories. It is reactive without being clearly allergic.

The clinical flag that should prompt consideration of dysbiosis as the underlying driver: treatment outcomes that are disproportionately poor for the quality of the intervention. Standard ceramide-containing barrier products that work predictably for most clients produce diminished or short-lived results. Professional treatments that reliably improve barrier function show weaker-than-expected responses or faster regression. The missing variable is a microbial environment that is actively undoing the structural repair being applied.

Skin Conditions Characterised by Dysbiosis

Atopic dermatitis is the best-characterised presentation. Lesional AD skin shows dramatically reduced microbial diversity, loss of S. epidermidis and Corynebacterium populations, and S. aureus domination reaching 90% of culturable bacteria on active lesions. FLG loss-of-function is associated with altered lesional microbiome composition – the microbiome in genetically susceptible individuals is not merely altered by barrier dysfunction but shaped by the same genetic architecture that produced the barrier vulnerability, though the specific directionality of S. aureus enrichment by FLG genotype varies by population studied. ^[8]

Acne vulgaris represents a distinct dysbiosis pattern. The problem is not C. acnes presence – commensal C. acnes is providing PPARα-mediated barrier signals in healthy follicular conditions. It is the community shift in which C. acnes over-representation (particularly certain phylotypes) within an obstructed, altered-pH follicular environment drives inflammatory signalling. A 2025 clinical study using next-generation sequencing confirmed that C. acnes comprised 31.2% of the total microbiome in acne-affected skin, declining to 16.2% after CAP treatment alongside improved diversity indices. ^[13]

Perimenopausal skin is a clinically underappreciated dysbiosis context. Oestrogen decline during perimenopause reduces ceramide synthesis and filaggrin expression; associated microbiome shifts include documented declines in C. acnes relative abundance and, in a 2024 pilot study using 16S rRNA gene sequencing (n=44), significantly reduced Lactobacillus abundance in postmenopausal compared to premenopausal skin – a shift proposed to reflect declining oestrogen reducing glycogen availability, the substrate Lactobacillus requires for growth. ^[10] The simultaneous loss of both C. acnes and Lactobacillus populations removes two independent surface acidification mechanisms at the same time as sebum production declines. The result is a quadruple reduction: barrier protein synthesis, barrier lipid synthesis, and acid mantle acidification capacity from two microbial sources all declining concurrently – creating dysbiosis-permissive conditions from four partially independent pathways.

Rosacea and psoriasis show dysbiosis associations with established evidence, though the causal mechanisms are less precisely characterised than in AD. In rosacea, the KLK5/LL-37 inflammatory loop that drives neurovascular reactivity runs through the acid mantle’s desquamation control system – making pH dysregulation a contributing mechanism even when microbial shifts are not the primary driver.